Treatment of cancer

Results: 1774



#Item
991MASCCTM TEACHING TOOL FOR PATIENTS RECEIVING ORAL AGENTS FOR CANCER This teaching tool has been prepared to assist health care providers in the assessment and education of patients receiving oral agents as treatment for

MASCCTM TEACHING TOOL FOR PATIENTS RECEIVING ORAL AGENTS FOR CANCER This teaching tool has been prepared to assist health care providers in the assessment and education of patients receiving oral agents as treatment for

Add to Reading List

Source URL: www.mascc.org

Language: English - Date: 2012-07-02 09:26:51
992The AAPS Journal, Vol. 16, No. 5, September[removed]) DOI: [removed]s12248[removed]Research Article Lower Exposure and Faster Clearance of Bevacizumab in Gastric Cancer and the Impact of Patient Variables: Analysi

The AAPS Journal, Vol. 16, No. 5, September[removed]) DOI: [removed]s12248[removed]Research Article Lower Exposure and Faster Clearance of Bevacizumab in Gastric Cancer and the Impact of Patient Variables: Analysi

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English
993RAPID  PSYCHOSOCIAL  ASSESSMENT   OF  CHILDREN  IN  DONETSK  OBLAST     EXECUTIVE  SUMMARY   Context   Amidst  rapid  geopolitical  changes  and  military  operation

RAPID  PSYCHOSOCIAL  ASSESSMENT   OF  CHILDREN  IN  DONETSK  OBLAST     EXECUTIVE  SUMMARY   Context   Amidst  rapid  geopolitical  changes  and  military  operation

Add to Reading List

Source URL: www.unicef.org

Language: English - Date: 2014-09-20 10:44:24
994Protocol I199911: A PHASE I CLINICAL TRIAL OF mTOR INHIBITION WITH SIROLIMUS FOR ENHANCING ALVAC(2)-NY-ESO1(M)/TRICOM VACCINE INDUCED ANTI-TUMOR IMMUNITY IN OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CANCER Kunle Odu

Protocol I199911: A PHASE I CLINICAL TRIAL OF mTOR INHIBITION WITH SIROLIMUS FOR ENHANCING ALVAC(2)-NY-ESO1(M)/TRICOM VACCINE INDUCED ANTI-TUMOR IMMUNITY IN OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CANCER Kunle Odu

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-31 11:43:35
9953. GENERAL CONSIDERATIONS FOR THE ANALYSIS OF CASE-CONTROL STUDIES 3.1 Bias, confounding and causality 3.2 Criteria for assessing causality 3.3 Initial treatment of the data

3. GENERAL CONSIDERATIONS FOR THE ANALYSIS OF CASE-CONTROL STUDIES 3.1 Bias, confounding and causality 3.2 Criteria for assessing causality 3.3 Initial treatment of the data

Add to Reading List

Source URL: www.iarc.fr

Language: English - Date: 2012-04-27 07:12:51
996ACTA OTORHINOLARYNGOLOGICA ITALICA 2014;34:[removed]Head and neck Comparisons of quality of life for patients with nasopharyngeal carcinoma after treatment with

ACTA OTORHINOLARYNGOLOGICA ITALICA 2014;34:[removed]Head and neck Comparisons of quality of life for patients with nasopharyngeal carcinoma after treatment with

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English
997Draft[removed]Executive Summary In 1977, tamoxifen was approved by the FDA for the treatment of metastatic breast cancer. Subsequently the drug received approval for adjuvant treatment of breast cancer,

Draft[removed]Executive Summary In 1977, tamoxifen was approved by the FDA for the treatment of metastatic breast cancer. Subsequently the drug received approval for adjuvant treatment of breast cancer,

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2006-09-28 09:40:13
998Federal Legislative Agenda Today, almost 700,000 Americans are fighting the devastating symptoms, lack of effective treatment options, bleak survival rates, and crippling financial implications of a brain tumor diagnosis

Federal Legislative Agenda Today, almost 700,000 Americans are fighting the devastating symptoms, lack of effective treatment options, bleak survival rates, and crippling financial implications of a brain tumor diagnosis

Add to Reading List

Source URL: blog.braintumor.org

Language: English - Date: 2014-08-12 12:34:34
999Can I join this study? We are looking for White and Black adults over the age of 60 currently receiving outpatient treatment for cancer. Any type of cancer is acceptable. We are looking for individuals who are experienci

Can I join this study? We are looking for White and Black adults over the age of 60 currently receiving outpatient treatment for cancer. Any type of cancer is acceptable. We are looking for individuals who are experienci

Add to Reading List

Source URL: agingstudies.cbcs.usf.edu

Language: English - Date: 2010-07-14 09:47:17
1000CANCER PREVENTION AND TREATMENT DEMONSTRATION FOR ETHNIC AND RACIAL MINORITIES The Medicare Cancer Prevention and Treatment Demonstration for Racial and Ethnic Minorities used a randomized control design to study the imp

CANCER PREVENTION AND TREATMENT DEMONSTRATION FOR ETHNIC AND RACIAL MINORITIES The Medicare Cancer Prevention and Treatment Demonstration for Racial and Ethnic Minorities used a randomized control design to study the imp

Add to Reading List

Source URL: cms.gov

Language: English - Date: 2012-04-04 17:10:37